| Year |
Citation |
Score |
| 2000 |
Duvoisin RC. Genetic Factors in Parkinson's Disease Loss, Grief & Care. 8: 41-53. DOI: 10.1300/J132V08N03_09 |
0.327 |
|
| 1999 |
Golbe LI, Di Iorio G, Lazzarini A, Vieregge P, Gershanik OS, Bonavita V, Duvoisin RC. The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies. Advances in Neurology. 80: 165-70. PMID 10410717 |
0.571 |
|
| 1997 |
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, ... ... Duvoisin RC, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (New York, N.Y.). 276: 2045-7. PMID 9197268 DOI: 10.1126/Science.276.5321.2045 |
0.349 |
|
| 1996 |
Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, Duvoisin RC. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Annals of Neurology. 40: 767-75. PMID 8957018 DOI: 10.1002/Ana.410400513 |
0.342 |
|
| 1996 |
Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science (New York, N.Y.). 274: 1197-9. PMID 8895469 DOI: 10.1126/Science.274.5290.1197 |
0.335 |
|
| 1995 |
Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 450-4. PMID 7565825 DOI: 10.1002/Mds.870100408 |
0.393 |
|
| 1994 |
Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC. Meige syndrome in the spectrum of Lewy body disease. Neurology. 44: 1432-6. PMID 8058144 DOI: 10.1212/Wnl.44.8.1432 |
0.361 |
|
| 1994 |
Duvoisin RC. Differential diagnosis of PSP. Journal of Neural Transmission. Supplementum. 42: 51-67. PMID 7964697 DOI: 10.1007/978-3-7091-6641-3_5 |
0.351 |
|
| 1992 |
Duvoisin RC. Overview of Parkinson's disease. Annals of the New York Academy of Sciences. 648: 187-93. PMID 1637046 DOI: 10.1111/J.1749-6632.1992.Tb24537.X |
0.378 |
|
| 1992 |
Duvoisin RC. A brief history of parkinsonism. Neurologic Clinics. 10: 301-16. PMID 1584174 DOI: 10.1016/S0733-8619(18)30211-1 |
0.345 |
|
| 1992 |
Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900. PMID 1407569 DOI: 10.1212/Wnl.42.10.1894 |
0.381 |
|
| 1992 |
Duvoisin RC, Johnson WG. Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathology (Zurich, Switzerland). 2: 309-20. PMID 1341965 DOI: 10.1111/J.1750-3639.1992.Tb00708.X |
0.362 |
|
| 1990 |
Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Annals of Neurology. 27: 276-82. PMID 2158268 DOI: 10.1002/Ana.410270309 |
0.372 |
|
| 1990 |
Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clinical Neuropharmacology. 13: 36-47. PMID 1689615 DOI: 10.1097/00002826-199002000-00004 |
0.386 |
|
| 1989 |
Golbe LI, Miller DC, Duvoisin RC. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 147-52. PMID 2543919 DOI: 10.1002/Mds.870040206 |
0.319 |
|
| 1988 |
Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. European Journal of Pharmacology. 146: 313-8. PMID 3131149 DOI: 10.1016/0014-2999(88)90308-1 |
0.3 |
|
| 1988 |
Golbe LI, Lieberman AN, Muenter MD, Ahlskog JE, Gopinathan G, Neophytides AN, Foo SH, Duvoisin RC. Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease. Clinical Neuropharmacology. 11: 45-55. PMID 3127050 DOI: 10.1097/00002826-198802000-00004 |
0.347 |
|
| 1988 |
Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Advances in Neurology. 50: 377-84. PMID 3041760 |
0.358 |
|
| 1987 |
Schonfeld SM, Golbe LI, Sage JI, Safer JN, Duvoisin RC. Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 263-78. PMID 3504554 DOI: 10.1002/Mds.870020404 |
0.303 |
|
| 1987 |
Duvoisin RC, Golbe LI, Lepore FE. Progressive supranuclear palsy. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 14: 547-54. PMID 3315157 DOI: 10.1017/S0317167100038099 |
0.334 |
|
| 1987 |
Duvoisin R. History of parkinsonism Pharmacology and Therapeutics. 32: 1-17. PMID 3295896 DOI: 10.1016/0163-7258(87)90061-1 |
0.396 |
|
| 1986 |
Nygaard TG, Duvoisin RC. Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology. 36: 1424-8. PMID 3762960 DOI: 10.1212/Wnl.36.11.1424 |
0.315 |
|
| 1986 |
Golbe LI, Cody RA, Duvoisin RC. Smoking and Parkinson's disease. Search for a dose-response relationship. Archives of Neurology. 43: 774-8. PMID 3729757 DOI: 10.1001/Archneur.1986.00520080022014 |
0.315 |
|
| 1986 |
Sage JI, Duvoisin RC. Long-term efficacy of pergolide in patients with Parkinson's disease. Clinical Neuropharmacology. 9: 160-4. PMID 3708601 DOI: 10.1097/00002826-198604000-00007 |
0.355 |
|
| 1986 |
Lepore FE, Duvoisin RC. 'Apraxia' of eye opening in idiopathic Parkinson's disease Neurology. 36: 134-134. DOI: 10.1212/Wnl.36.1.134-A |
0.321 |
|
| 1985 |
Duvoisin RC. Parkinson's disease: intrauterine influence in twins? Neurology. 35: 774-5. PMID 3990979 DOI: 10.1212/Wnl.35.5.774-C |
0.373 |
|
| 1985 |
Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Life Sciences. 36: 231-6. PMID 3917525 DOI: 10.1016/0024-3205(85)90064-5 |
0.316 |
|
| 1985 |
Sage JI, Duvoisin RC. Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study. Clinical Neuropharmacology. 8: 260-5. PMID 3899352 DOI: 10.1097/00002826-198509000-00006 |
0.387 |
|
| 1984 |
Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology. 23: 711-3. PMID 6611514 DOI: 10.1016/0028-3908(84)90170-9 |
0.319 |
|
| 1984 |
Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science (New York, N.Y.). 224: 1451-3. PMID 6610213 DOI: 10.1126/Science.6610213 |
0.356 |
|
| 1984 |
Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature. 311: 467-9. PMID 6332989 DOI: 10.1038/311467A0 |
0.32 |
|
| 1983 |
Gershanik O, Heikkila RE, Duvoisin RC. Effects of dopamine depletion on rotational behavior to dopamine agonists. Brain Research. 261: 358-60. PMID 6831221 DOI: 10.1016/0006-8993(83)90645-5 |
0.592 |
|
| 1983 |
Gershanik O, Heikkila RE, Duvoisin RC. Behavioral correlations of dopamine receptor activation. Neurology. 33: 1489-92. PMID 6605497 DOI: 10.1212/Wnl.33.11.1489 |
0.579 |
|
| 1982 |
Duvoisin RC, Heikkila RE, Manzino L. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Neurology. 32: 1387-91. PMID 6128698 DOI: 10.1212/Wnl.32.12.1387 |
0.322 |
|
| 1982 |
Gershanik OS, Heikkila RE, Duvoisin RC, Manzino L. Behavioral correlates of dopamine receptor interaction Neurology. 32: A 161. |
0.528 |
|
| 1980 |
Duvoisin RC, Mendoza MM, Yahr MD. A comparative study of bromocriptine and levodopa in Parkinson's disease. Advances in Biochemical Psychopharmacology. 23: 271-5. PMID 7395618 |
0.553 |
|
| 1980 |
Marsden CD, Duvoisin R. Scoliosis and Parkinson's Disease Jama Neurology. 37: 253-254. PMID 7362496 DOI: 10.1001/Archneur.1980.00500530091025 |
0.514 |
|
| 1979 |
Gershanik OS, Heikkila RE, Duvoisin RC. Asymmetric action of intraventricular monoamine neurotoxins. Brain Research. 174: 345-50. PMID 487133 DOI: 10.1016/0006-8993(79)90860-6 |
0.495 |
|
| 1979 |
Gershanik OS, Heikkila RE, Duvoisin RC. The role of serotonin neurons in the action of L-dopa in an animal model of parkinsonism Neurology. 29: 553. |
0.55 |
|
| 1975 |
Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism Journal of Neurology, Neurosurgery and Psychiatry. 38: 787-793. PMID 1185199 DOI: 10.1136/jnnp.38.8.787 |
0.409 |
|
| 1975 |
Duvoisin RC. Antagonism of Levodopa by Papaverine Jama: the Journal of the American Medical Association. 231: 845. PMID 1172755 DOI: 10.1001/Jama.1975.03240200043025 |
0.397 |
|
| 1975 |
Marsden CD, Duvoisin RC, Jenner P, Parkes JD, Pycock C, Tarsy D. Relationship between animal models and clinical parkinsonism. Advances in Neurology. 9: 165-75. PMID 1146651 |
0.354 |
|
| 1974 |
Marsden CD, Dolphin A, Duvoisin RC, Jenner P, Tarsy D. Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Research. 77: 521-5. PMID 4854165 DOI: 10.1016/0006-8993(74)90643-X |
0.511 |
|
| 1972 |
Duvoisin RC. Diphenidol for Levodopa Induced Nausea and Vomiting Jama: the Journal of the American Medical Association. 221: 1408. PMID 5068561 DOI: 10.1001/Jama.1972.03200250048015 |
0.311 |
|
| 1972 |
Yahr MD, Duvoisin RC. Pyridoxine and Levodopa in The Treatment of Parkinsonism Jama: the Journal of the American Medical Association. 220: 861. PMID 5067358 DOI: 10.1001/Jama.1972.03200060085023 |
0.538 |
|
| 1972 |
Duvoisin RC, Lobo-Antunes J, Yahr MD. Response of patients with postencephalitic Parkinsonism to levodopa Journal of Neurology Neurosurgery and Psychiatry. 35: 487-495. PMID 5049808 DOI: 10.1136/Jnnp.35.4.487 |
0.592 |
|
| 1972 |
Yahr MD, Duvoisin RC, Côté L, Cohen G. Pyridoxine, DOPA, and Parkinsonism Advances in Biochemical Psychopharmacology. 4: 185-194. PMID 4555927 |
0.573 |
|
| 1972 |
Yahr MD, Duvoisin RC. Drug therapy of parkinsonism New England Journal of Medicine. 287: 20-24. PMID 4555145 DOI: 10.1056/Nejm197207062870105 |
0.591 |
|
| 1971 |
Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association. 96: 55-58. PMID 5159129 |
0.492 |
|
| 1971 |
Yahr MD, Duvoisin RC. Pyridoxine, Levodopa, and L-α-Methyldopa Hydrazine Regimen in Parkinsonism Jama: the Journal of the American Medical Association. 216: 2141. DOI: 10.1001/Jama.1971.03180390051016 |
0.607 |
|
| 1971 |
Duvoisin RC. L-Dopa and Parkinsonism. Archives of Neurology. 25: 281-281. DOI: 10.1001/Archneur.1971.00490030107016 |
0.405 |
|
| 1970 |
Barrett RE, Yahr MD, Duvoisin RC. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa Neurology. 20: 107-113. PMID 5529472 DOI: 10.1212/Wnl.20.11_Part_2.107 |
0.512 |
|
| 1970 |
Cote L, Yahr MD, Duvoisin RC, Wolf A, Marksbery W. Analysis of deaths in Parkinson patients on long-term levodopa therapy Transactions of the American Neurological Association. 95: 73-77. PMID 4998770 |
0.489 |
|
| 1970 |
Duvoisin RC. An Atlas of Clinical Neurology. Archives of Neurology. 22: 191-191. DOI: 10.1001/Archneur.1970.00480200097015 |
0.303 |
|
| 1969 |
Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of Parkinsonism With Levodopa Archives of Neurology. 21: 343-354. PMID 5820999 DOI: 10.1001/Archneur.1969.00480160015001 |
0.581 |
|
| 1969 |
Duvoisin RC, Yahr MD, Coté LD. Pyridoxine reversal of L-dopa effects in Parkinsonism Transactions of the American Neurological Association. 94: 81-84. PMID 5374494 |
0.521 |
|
| 1968 |
Yahr MD, Duvoisin RC. Medical therapy of Parkinsonism Modern Treatment. 5: 283-300. PMID 5655945 |
0.478 |
|
| 1968 |
Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism Transactions of the American Neurological Association. 93: 56-63. PMID 4885744 |
0.495 |
|
| 1967 |
Duvoisin RC. Cholinergic-Anticholinergic Antagonism in Parkinsonism Archives of Neurology. 17: 124-136. PMID 4382112 DOI: 10.1001/Archneur.1967.00470260014002 |
0.367 |
|
| 1965 |
Duvoisin RC, Yahr MD. Posterior fossa aneurysms Neurology. 15: 231-241. PMID 14262321 DOI: 10.1212/Wnl.15.3.231 |
0.467 |
|
| 1965 |
Duvoisin RC, Yahr MD. Encephalitis and Parkinsonism Archives of Neurology. 12: 227-239. PMID 14247380 DOI: 10.1001/Archneur.1965.00460270003001 |
0.558 |
|
| 1965 |
Yahr MD, Duvoisin RC, Cowen D. Encephalopathy associated with carcinoma. Transactions of the American Neurological Association. 90: 80-6. PMID 5857782 |
0.399 |
|
| 1963 |
DUVOISIN RC, YAHR MD, SCHWEITZER MD, MERRITT HH. PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA. Archives of Neurology. 9: 232-6. PMID 14049396 DOI: 10.1001/Archneur.1963.00460090038003 |
0.595 |
|
| 1962 |
Duvoisin RC, Yahr MD. Compressive spinal cord and root syndromes in achondroplastic dwarfs Neurology. 12: 202-207. PMID 13888761 DOI: 10.1212/Wnl.12.3.202 |
0.466 |
|
| Show low-probability matches. |